Filing Flows › McKesson (MCK) › Recalls, complaints & regulation
McKesson (MCK): recalls and Federal Register
McKesson (MCK) beyond its filings: 2 recalls in the last 12 months (284 in five years, 1 Class I); 1 Federal Register document in a year.
Latest recalls
- 2026-07-08 · FDA drug · Gemcitabine Injection, 1 g per 26.3 mL (38 mg/mL), 26.3 mL Single-Dose Vial, For Intravenous Infusion ONLY, Rx only, Manufactured by: THYMOORGAN PHARMAZIE GmbH,
- 2026-02-18 · FDA drug · UDENYCA, pegfilgrastim-cbqv injection, 6 mg/0.6mL Single Dose Prefilled Syringe, Rx only, Manufactured by Accord BioPharma, Inc., 8041 Arco Corporate Drive, Su
- 2025-08-27 · FDA device · Clearview Strep A Exact II Dipstick Respiratory Kit, CLIA Waived. Catalog Number: 4581225020
- 2025-07-30 · FDA drug · EVENITY, (romosozumab -aqqg) injection, 105mg/1.17 mL, For Subcutaneous Use Only, Rx Only, Manufactured by: Amgen Inc., Thousand Oaks, CA 91320, NDC 55513-880-0
- 2025-07-30 · FDA drug · BENLYSTA (belimumab) for injection, 400 mg/20 mL vial, Rx only, NDC 49401-102-01, GSK.
- 2025-07-30 · FDA drug · PROLIA (denosumab), injection, 60mg/mL, For Subcutaneous Use Only, Rx Only, Manufactured by: Amgen Inc., Thousand Oaks, CA 91320, NDC 55513-710-21
- 2025-06-04 · FDA device · SEKISUI DIAGNOSTICS LLC SERUM HCG OSOMGENZME CONTROL SET.
- 2025-06-04 · FDA device · ABBOTT POINT OF CARE TEST CREA I-STAT (25/BX) ABBTPT CARTRIDGE.
McKesson's latest quarter
McKesson, Q2 FY27: revenue $111.0B (+8% year over year), operating margin 1.4%, net earnings $1.2B, operating cash flow $3.1B. The chart follows the revenue to costs, profit and cash.
Questions
Has McKesson had any recalls?
284 recalls on file over five years from the FDA, CPSC and NHTSA; 2 in the last 12 months.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.